Avalo Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Avalo Therapeutics Inc
Access all reports
Avalo Therapeutics Inc. is a U.S.-based biotechnology company focused on the development of targeted therapies for immune-mediated diseases. The company specializes in discovering and advancing treatments for autoimmune and rare diseases by leveraging its expertise in immunology and precision medicine. Avalo Therapeutics Inc. conducts research across various stages of drug development, from early discovery to clinical trials. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
AVTX
Country
🇺🇸 United States